Latest News about ITCI

Recent news which mentions ITCI

< Previous 1 2 3 4 Next >

Analyst Expectations for Intra-Cellular Therapies's Future

June 05, 2023

Recap: Intra-Cellular Therapies Q1 Earnings

May 04, 2023

A Preview Of Intra-Cellular Therapies's Earnings

May 03, 2023

Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2023

April 20, 2023

10 Health Care Stocks Whale Activity In Today's Session

April 07, 2023

Analyst Ratings for Intra-Cellular Therapies

March 29, 2023

Airbnb To Rally Around 59%? Here Are 10 Other Analyst Forecasts For Wednesday

March 29, 2023

Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

March 28, 2023

Intra-Cellular Stock Surges As Antipsychotic Shows Benefit In Depression Patients With Mixed Features

March 28, 2023

Why Intra-Cellular Therapies Climbed Tuesday

March 28, 2023

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

March 28, 2023

Analyst Ratings for Intra-Cellular Therapies

March 02, 2023

Earnings Scheduled For March 1, 2023

March 01, 2023

Earnings Outlook For Intra-Cellular Therapies

February 28, 2023

Looking Into Intra-Cellular Therapies's Return On Capital Employed

November 23, 2022

Recap: Intra-Cellular Therapies Q3 Earnings

November 03, 2022

Intra-Cellular Therapies's Earnings: A Preview

November 02, 2022

Looking Into Intra-Cellular Therapies's Return On Capital Employed

September 02, 2022

Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2022

August 22, 2022

Illumina, Poshmark, Olo And Some Other Big Losers From Friday

August 15, 2022

Q2 EPS Miss for Intra-Cellular Therapies (ITCI) Is 16 Cents

August 12, 2022

Where Intra-Cellular Therapies Stands With Analysts

August 11, 2022

Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful

August 09, 2022

Intra-Cellular Therapies: Q2 Earnings Insights

August 09, 2022

Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022

July 07, 2022

Analyst Ratings for Intra-Cellular Therapies

July 07, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2022

June 14, 2022

Looking Into Intra-Cellular Therapies's Return On Capital Employed

June 09, 2022

Why Intra-Cellular Therapies Stock Rose 21.4% This Week

May 12, 2022

103 Biggest Movers From Yesterday

May 11, 2022

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.